ICD-10 Coding for Urothelial Cell Carcinoma(C67.2)
Complete ICD-10-CM coding and documentation guide for Urothelial Cell Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Urothelial Cell Carcinoma
C67.0-C67.9Primary Range
Malignant neoplasm of bladder
This range covers all malignant neoplasms of the bladder, including urothelial carcinoma.
Malignant neoplasm of renal pelvis and ureter
This range includes urothelial carcinoma of the upper urinary tract, such as the renal pelvis and ureter.
Key Information: ICD-10 code for urothelial cell carcinoma
Essential facts and insights about Urothelial Cell Carcinoma
Primary ICD-10-CM Code for urothelial cell carcinoma
Decision Criteria
clinical Criteria
- Confirmed urothelial carcinoma on lateral bladder wall
documentation Criteria
- Pathology report must specify tumor location
Applicable To
- Urothelial carcinoma of lateral bladder wall
Excludes
- Secondary malignant neoplasm of bladder (C79.11)
Clinical Validation Requirements
- Pathology report confirming urothelial carcinoma
- Imaging showing tumor on lateral wall
Code-Specific Risks
- Incorrectly coding unspecified location when lateral wall is documented
Coding Notes
- Ensure tumor location is specified to avoid unspecified coding.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Encounter for antineoplastic chemotherapy
Z51.11Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Neoplasm of unspecified behavior of bladder
D49.4Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Urothelial Cell Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C67.2.
Impact
Clinical: May lead to incorrect treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement.
Mitigation Strategy
Review pathology reports for location details, Train staff on importance of detailed documentation
Impact
Reimbursement: Potential underpayment due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Decreased accuracy in cancer registry data.
Mitigation Strategy
Specify and code the exact location of the tumor, such as C67.2 for lateral wall.
Impact
Coding C67.9 without specifying tumor location increases audit risk.
Mitigation Strategy
Ensure all documentation includes specific tumor location.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Urothelial Cell Carcinoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Urothelial Cell Carcinoma
Use these documentation templates to ensure complete and accurate documentation for Urothelial Cell Carcinoma. These templates include all required elements for proper coding and billing.
Initial Diagnosis of Urothelial Carcinoma
Specialty: UrologyRequired Elements
- Patient history
- Cystoscopy findings
- Pathology report
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Urothelial Cell Carcinoma? Ask your questions below.